Home
Who We Are
Our Direction
Our Journey
Group Structure
Leadership
Board of Directors
Audit Committee
Executive Team
Organization Chart
Our Pride
What We Do
Our Products
Lime as Human Chemical
How We Make Lime
Markets & Products
Our Services
Our Operations
Thailand
Vietnam
India
Australia
Sustainability
Sustainability
Environment
Society
Activities
Investors
IR Home
Financial Information
Financial Highlights
Financial Statements and MD&A
Stock Information
Stock Quote
Investment Calculator
Shareholder Information
Major Shareholders
Dividend Information
Shareholders' Meetings
Analyst Coverage
Publications
Annual Filings
Prospectus
Company Snapshot
Resource Center
IR Calendar
Presentations & Webcasts
Newsroom
SET Announcements
Press Releases
Information Inquiry
IR Contact
FAQ
News Subscription
Governance
Corporate Governance Policy
Whistleblowing
News and Media
Our People
Life at Chememan
Job Openings
Contact Us
EN
TH
Who We Are
Who We Are
Our Direction
Our Journey
Group Structure
Leadership
Board of Directors
Audit Committee
Executive Team
Organization Chart
Our Pride
What We Do
What We Do
Our Products
Lime as Human Chemical
How We Make Lime
Markets & Products
Our Services
Our Operations
Our Operations
Thailand
Vietnam
India
Australia
Sustainability
Sustainability
Sustainability
Environment
Society
Activities
Investors
IR Home
Financial Information
Financial Highlights
Financial Statements and MD&A
Stock Information
Stock Quote
Investment Calculator
Shareholder Information
Major Shareholders
Dividend Information
Shareholders' Meetings
Analyst Coverage
Publications
Annual Filings
Prospectus
Company Snapshot
Resource Center
IR Calendar
Presentations & Webcasts
Newsroom
SET Announcements
Press Releases
Information Inquiry
IR Contact
FAQ
News Subscription
Governance
Governance
Corporate Governance Policy
Whistleblowing
Our People
Our People
Life at Chememan
Job Openings
Investors
IR Home
IR Home
SET Announcements
08
Aug 2025
Management Discussion and Analysis Quarter 2 Ending 30 Jun 2025
Read More
Financial Statement 2Q2025
Download
MD&A 2Q2025
Download
Form 56-1 One Report 2024
Download
Factsheet
Read More
Operating Results 2Q2025
Revenue from Sales and Services
950 MB
(1.5%)
YoY
Adjusted EBITDA
275 MB
(15.5%)
YoY
Gross Profit
353 MB
(1.3%)
YoY
Adjusted Net Profit Attributable to CMAN
159 MB
(50.5%)
YoY
Major Shareholders
IR Contact
Financial Statement Quarter 2/2025 (Reviewed)
Report of the Auditor
View Online
Download
Financial Statement
View Online
Download
Note to Financial Statement
View Online
Download
Contact